Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Comparison of patient-reported frailty phenotype and International Myeloma Working Group frailty index shows fair agreement; frail patients by PRFP had higher treatment side effects, disease symptoms, worse future perspectives, and body image.”
Title: Assessing frailty in patients with relapsed/refractory multiple myeloma: A comparison between the patient-reported frailty phenotype and the International Myeloma Working Group frailty index
Authors: Daniela Krepper, Francesco Sparano, Johannes M. Giesinger, Gianluca Gaidano, Pasquale Niscola, Katia Codeluppi, Elisabetta Antonioli, Catello Califano, Lajos Floro, Ombretta Annibali, Claudio Fozza, Agostino Tafuri, Patrizio Mazza, Leonardo Potenza, Marco Vignetti, Michele Cavo, Maria Teresa Petrucci, Fabio Efficace
You can read the Full Article in the Journal of Geriatric Oncology.
More posts featuring Robert Orlowski.
